Ticker Details
Erasca, Inc.
IPO Date:	July 16, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$4.79B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.21 | 3.75%
Avg Daily Range (30 D):	$0.39 | 3.18%
Avg Daily Range (90 D):	$0.29 | 4.64%

Institutional Daily Volume
Avg Daily Volume:	1.12M
Avg Daily Volume (30 D):	3.83M
Avg Daily Volume (90 D):	3.76M

Trade Size
Avg Trade Size (Sh.):	141
Avg Trade Size (Sh.) (30 D):	106
Avg Trade Size (Sh.) (90 D):	141

Institutional Trades
Total Institutional Trades:	692
Avg Institutional Trade:	$1.96M
Avg Institutional Trade (30 D):	$2.37M
Avg Institutional Trade (90 D):	$1.99M
Avg Institutional Trade Volume:	.36M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.13M
Avg Closing Trade (30 D):	$5.99M
Avg Closing Trade (90 D):	$4.08M
Avg Closing Volume:	537.47K

News

Jan 26, 2026 @ 12:52 PM Why Is Cancer Drug Developer Erasca Stock Trading ... Source: Vandana Singh

Jan 23, 2026 @ 9:01 PM Erasca Announces Closing of Upsized Public Offerin... Source: Globe Newswire

Jan 22, 2026 @ 1:54 AM Erasca Announces Pricing of Upsized Public Offerin... Source: Na

Jan 14, 2026 @ 3:52 PM Precision Killers: Why Big Pharma is Betting Billi... Source: Prnewswire

Aug 13, 2025 @ 2:16 AM Erasca Narrows Loss 46% in Fiscal Q2 Source: Na

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-.11	$-.12	$-.11
Diluted EPS	$-.11	$-.12	$-.11
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-30.61M	$-33.88M	$-30.97M
Operating Income / Loss	$-34.55M	$-38.13M	$-35.63M
Cost of Revenue
Net Cash Flow	$4.09M	$-4.34M	$2.74M
PE Ratio